Clinical Trial Update: NAM-Trial: Multiferon in Malignant Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for Multiferon in malignant melanoma with locoregional metastases (stages IIIB/C) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Multiferon (Interferon-alpha)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Locoregional Metastases in Malignant Melanoma Stages IIIB/C | Phase 2 | Status: COMPLETED